Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5176
MIND Technology
MIND
$30.4M
| $4 | ﹤0.01% |
+1
| New | +$5 |
2026 Q3
0 quarters
|
|
5177
Mobix Labs
MOBX
$10.1M
| $4 | ﹤0.01% |
5
-212
| -98% | -$307 |
2026 Q2
1 quarter
|
|
5178
Netcapital
NCPL
$10.1M
| $4 | ﹤0.01% |
+3
| New | +$2 |
2026 Q3
0 quarters
|
|
5179
Vyome Holdings
HIND
$11.1M
| $4 | ﹤0.01% |
2
-24
| -92% | -$51 |
2026 Q2
1 quarter
|
|
5180
Retractable Technologies
RVP
$16.9M
| $4 | ﹤0.01% |
6
| – | – |
2026 Q2
1 quarter
|
|
5181
Presidio Property Trust
SQFT
$1.15M
| $4 | ﹤0.01% |
3
-15
| -83% | -$27 |
2026 Q2
1 quarter
|
|
5182
Willamette Valley Vineyards
WVVI
$8.47M
| $4 | ﹤0.01% |
2
-8
| -80% | -$19 |
2026 Q2
1 quarter
|
|
5183
XTI Aerospace
XTIA
$34.3M
| $4 | ﹤0.01% |
4
-1,185
| -100% | -$1.57K |
2026 Q2
1 quarter
|
|
5184
Aspire-Lakewood Holdings, Inc. Warrant
ASBPW
$205
| $4 | ﹤0.01% |
291
| – | – |
2022 Q2
17 quarters
|
|
5185
Newton Golf Co
NWTG
$4.03M
| $4 | ﹤0.01% |
+4
| New | +$5 |
2026 Q3
0 quarters
|
|
5186
Allarity Therapeutics
ALLR
$15.4M
| $3 | ﹤0.01% |
+3
| New | +$4 |
2026 Q3
0 quarters
|
|
5187
Amesite
AMST
$3.37M
| $3 | ﹤0.01% |
+3
| New | +$3 |
2026 Q3
0 quarters
|
|
5188
Paradium.AI, Inc.
PAAI
$42.5M
| $3 | ﹤0.01% |
2
-509
| -100% | -$595 |
2025 Q2
5 quarters
|
|
5189
Ascent Solar Technologies
ASTI
$14.2M
| $3 | ﹤0.01% |
+1
| New | +$3 |
2026 Q3
0 quarters
|
|
5190
AMC Robotics
AMCI
$26.3M
| $3 | ﹤0.01% |
+1
| New | +$4 |
2026 Q3
0 quarters
|
|
5191
Aware
AWRE
$21.2M
| $3 | ﹤0.01% |
3
-94
| -97% | -$114 |
2026 Q2
1 quarter
|
|
5192
DELISTED
BIOATLA INC
BCAB
| $3 | ﹤0.01% |
2
-99
| -98% | -$346 |
2026 Q2
1 quarter
|
|
5193
Beneficient
BENF
$11M
| $3 | ﹤0.01% |
2
-58
| -97% | -$141 |
2026 Q2
1 quarter
|
|
5194
Bionano Genomics
BNGO
$16.1M
| $3 | ﹤0.01% |
2
-1
| -33% | -$1 |
2026 Q2
1 quarter
|
|
5195
Envoy Medical
COCH
$55.3M
| $3 | ﹤0.01% |
1
-24
| -96% | -$171 |
2026 Q2
1 quarter
|
|
5196
Energy Focus
EFOI
$25.7M
| $3 | ﹤0.01% |
+1
| New | +$3 |
2026 Q3
0 quarters
|
|
5197
Azio AI Holdings
AZIO
$8.94M
| $3 | ﹤0.01% |
2
-2,220
| -100% | -$3.27K |
2026 Q2
1 quarter
|
|
5198
Full House Resorts
FLL
$22.8M
| $3 | ﹤0.01% |
2
-216
| -99% | -$473 |
2021 Q1
22 quarters
|
|
5199
Gain Therapeutics
GANX
$45M
| $3 | ﹤0.01% |
2
-1,350
| -100% | -$2.46K |
2026 Q2
1 quarter
|
|
5200
IN8bio
INAB
$9.13M
| $3 | ﹤0.01% |
2
-26
| -93% | -$30 |
2026 Q2
1 quarter
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.